Viewing Study NCT00772694


Ignite Creation Date: 2025-12-25 @ 1:27 AM
Ignite Modification Date: 2026-01-11 @ 10:51 AM
Study NCT ID: NCT00772694
Status: UNKNOWN
Last Update Posted: 2008-10-24
First Post: 2008-10-14
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Sorafenib Monotherapy in Inoperable/Recurrent Germ Cell Carcinoma Refractory to Chemotherapy
Sponsor: Fondation Wygrajmy Zdrowie
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module